Effect of pregnane X receptor expression on drug resistance in breast cancer

ISSN： 1792-1074

Source： Oncology Letters, Vol.7, Iss.4, 2014-04, pp. : 1191-1196

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pregnane X Receptor and its Potential Role in Drug Resistance in Cancer Treatment

Recent Patents on Anti-Cancer Drug Discovery, Vol. 4, Iss. 1, 2009-01 ,pp. : 19-27

Bentham Science Publishers

Access to resources Recommend Favorite

Polymorphisms of the nuclear receptor pregnane X receptor and organic anion transporter polypeptides 1A2, 1B1, 1B3, and 2B1 are not associated with breast cancer risk

By Justenhoven Christina

Breast Cancer Research and Treatment, Vol. 125, Iss. 2, 2011-01 ,pp. : 563-569

Springer Publishing Company

Access to resources Recommend Favorite

Drug resistance in chemotherapy for breast cancer

By Saeki Toshiaki Tsuruo Takashi Sato Wakao Nishikawsa Kiyoshiro

Cancer Chemotherapy and Pharmacology, Vol. 56, Iss. 1, 2005-11 ,pp. : 84-89

Springer Publishing Company

Access to resources Recommend Favorite

Lower Level of MAPK Expression Is Associated with Anthracycline Resistance and Decreased Survival in Patients with Hormone Receptor Negative Breast Cancer

By Derin Duygu Eralp Yesim Ozluk Yasemin Yavuz Ekrem Guney Nese Saip Pinar Igci Abdullah Ozmen Vahit Kucucuk Seden Aslay Isik Aydiner Adnan Topuz Erkan

Cancer Investigation, Vol. 26, Iss. 7, 2008-08 ,pp. : 671-679

Informa Healthcare

Access to resources Recommend Favorite

Aberrant promoter DNA methylation inhibits bone morphogenetic protein 2 expression and contributes to drug resistance in breast cancer

By Du Min Su XiaoMei Zhang Tao Xing YongJun

Molecular Medicine Reports, Vol. 10, Iss. 2, 2014-08 ,pp. : 1051-1055

Spandidos Publications

Access to resources Recommend Favorite